FDAFDA PCAC reviews BPC-157, KPV, TB-500, MOTS-c (Jul 23) and DSIP, Semax, Epitalon (Jul 24, 2026) for 503A compounding eligibilityUPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORY12 peptides removed from FDA Category 2 (Apr 23, 2026) — removal is not approval; all remain pending PCAC reviewREGULATORYNo formal FDA reclassification published — no restricted peptide is legal to compound; 5 more peptides go to PCAC before Feb 2027RESEARCHA Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy [NCT07881783]RESEARCHStudy to Evaluate the Dose-Dependent Effect of Tirzepatide on Gastric Emptying in Adult Patients With Type 1 Diabetes [NCT07951658]RESEARCHA Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity [NCT06037252]RESEARCHA Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine [NCT07729462]RESEARCHHypersensitivity to Amylin in Post-Traumatic Headache [NCT07340775]RESEARCHEffects of Tirzepatide on Corneal Nerve Morphology and Other Ocular Parameters in Adults With Obesity [NCT07950371]NEWSSTAT+: Peptide market poised to explode with new Hims and Noom launchesRESEARCHAlleviating Carbohydrate Counting for Patients With Type-1 Diabetes Using a Closed Loop System With Weekly Subcutaneous Semaglutide [NCT06387199]RESEARCHWeight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity [NCT07423481]RESEARCHSEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years [NCT07845994]FDAFDA PCAC reviews BPC-157, KPV, TB-500, MOTS-c (Jul 23) and DSIP, Semax, Epitalon (Jul 24, 2026) for 503A compounding eligibilityUPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORY12 peptides removed from FDA Category 2 (Apr 23, 2026) — removal is not approval; all remain pending PCAC reviewREGULATORYNo formal FDA reclassification published — no restricted peptide is legal to compound; 5 more peptides go to PCAC before Feb 2027RESEARCHA Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy [NCT07881783]RESEARCHStudy to Evaluate the Dose-Dependent Effect of Tirzepatide on Gastric Emptying in Adult Patients With Type 1 Diabetes [NCT07951658]RESEARCHA Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity [NCT06037252]RESEARCHA Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine [NCT07729462]RESEARCHHypersensitivity to Amylin in Post-Traumatic Headache [NCT07340775]RESEARCHEffects of Tirzepatide on Corneal Nerve Morphology and Other Ocular Parameters in Adults With Obesity [NCT07950371]NEWSSTAT+: Peptide market poised to explode with new Hims and Noom launchesRESEARCHAlleviating Carbohydrate Counting for Patients With Type-1 Diabetes Using a Closed Loop System With Weekly Subcutaneous Semaglutide [NCT06387199]RESEARCHWeight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity [NCT07423481]RESEARCHSEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years [NCT07845994]

Только для исследовательских целей. Полный disclaimer →

Исследования/An article focusing on how probiotics and prebiotics might influence skin health and aging through their effects on the gut microbiome could attract interest in the clinical peptide therapy community.
Назад в Научную Библиотеку

An article focusing on how probiotics and prebiotics might influence skin health and aging through their effects on the gut microbiome could attract interest in the clinical peptide therapy community.

May 17, 2026
Share

Исходная статья

Microbiome and Human Aging: Probiotic and Prebiotic Potentials in Longevity, Skin Health and Cellular Senescence.

Boyajian Jacqueline Lena et al.Nutrients2021
Развивающиеся Исследования

Основано на развивающихся исследованиях. Эти выводы обещающи, но требуют дальнейшей проверки.

О данном анализе

Эта статья разбивает выводы из исходной статьи выше на доступный язык для сообщества исследований Peptide. Наша цель — подчеркнуть то, что наиболее важно — практические последствия, надежность доказательств и то, что это означает для текущих исследований.

The Gut-Skin Connection: How Probiotics and Prebiotics Could Slow Aging

Published: May 17, 2026 | Source: Nutrients (2021) | Category: Skin Health & Anti-Aging

Overview

A recent review in the journal Nutrients explores how probiotics and prebiotics might influence skin health and aging by balancing gut microbiota. This research highlights a potential new avenue for anti-aging therapies, particularly relevant to those interested in peptide-based treatments.

Study Background

The human microbiome has been increasingly recognized as a critical factor influencing various aspects of health, including aging and skin conditions. Prior studies have shown that the composition of gut bacteria can affect systemic inflammation and cellular senescence—processes linked with aging. This review aims to synthesize existing knowledge on how probiotics and prebiotics might mitigate these effects by promoting microbial balance.

What the Research Found

The study emphasizes that as we age, cells in our skin and other tissues undergo a process called senescence, where they stop dividing but remain metabolically active. Senescent cells secrete inflammatory molecules known collectively as SASP (senescence-associated secretory phenotype), which can contribute to aging-related diseases and skin disorders. The review suggests that the gut microbiome plays a crucial role in this process through its influence on systemic inflammation and metabolic activity via the gut-skin axis.

Moreover, the paper discusses how probiotics—live bacteria beneficial for health—and prebiotics—substances that promote the growth of beneficial microorganisms—could help maintain a healthy balance within the gut microbiota. This could potentially reduce cellular senescence and improve skin conditions associated with aging.

What This Means for Peptide Users

For individuals interested in peptide therapy, this research underscores the importance of considering the broader context of health maintenance beyond just topical or injectable treatments. Incorporating probiotics and prebiotics into a regimen might enhance overall skin health and potentially slow down aspects of cellular aging that peptides aim to address.

Limitations and Caveats

As a review paper, Nutrients does not present new experimental data but rather synthesizes existing literature. Therefore, the conclusions are based on indirect evidence linking microbiome health with aging processes. Additionally, while promising, the potential benefits of probiotics and prebiotics for skin health and longevity require further direct research to confirm.

How This Compares to Previous Research

This review aligns well with other studies suggesting a link between gut health and systemic inflammation. However, it adds nuance by focusing specifically on the role of probiotics and prebiotics in mitigating cellular senescence and its associated skin issues. The paper also highlights gaps in current knowledge regarding specific microbial compositions under senescent conditions.

Our Analysis

At PeptideVault, we find this review to be a valuable synthesis of existing literature that underscores the importance of gut health for overall aging processes. While it does not provide conclusive evidence on probiotics and prebiotics as anti-aging therapies, it opens up new avenues for future research. The paper's emphasis on the need for more detailed studies is well-founded.

Key Takeaways

  • Gut-Skin Axis: Maintaining a healthy gut microbiome could positively influence skin health.
  • Probiotics and Prebiotics: These dietary supplements may help reduce cellular senescence, though further research is needed to confirm their efficacy.
  • Comprehensive Approach: Combining peptide therapy with probiotics and prebiotics might offer a more holistic approach to anti-aging.

Original Source

Citation: Boyajian Jacqueline Lena, Ghebretatios Merry, Schaly Sabrina et al. (2021). Microbiome and Human Aging: Probiotic and Prebiotic Potentials in Longevity, Skin Health and Cellular Senescence.. Nutrients. DOI: 10.3390/nu13124550

Access:

---

This article is for informational and research purposes only. PeptideVault summarizes and analyzes published research. Always consult a licensed healthcare provider.

Примечание Редактора

Этот анализ был подготовлен командой исследований Peptide Contacts. Мы призываем читателей проверить полный исходный источник полная методология и данные. Исходное издание доступно на PubMed.

Comments

Sign in to join the discussion

Этот анализ сгенерирован на основе рецензированных исследований для образовательных целей только. Это не является медицинским советом. Всегда консультируйтесь с квалифицированным медицинским специалистом перед использованием каких-либо терапий на основе Peptide.